Form D · Biotechnology
RespireRx Pharmaceuticals Inc.
Glen Rock, NJ · CIK 0000849636
Offering snapshot reported Aug 12, 2020 · SEC filing
- Reported sold
- $193K Offering amount: $193K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 2, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 12, 2020 | Initial | $193,250 | No comparison | 2 | SEC filing |
| Aug 12, 2020 | Initial | $0 | No comparison | 1 | SEC filing |
| Sep 24, 2018 | Initial | $250,750 | No comparison | 10 | SEC filing |
| Sep 13, 2017 | Initial | $75,000 | No comparison | 1 | SEC filing |
| Mar 23, 2017 | Initial | $50,000 | No comparison | 1 | SEC filing |
| Jan 13, 2017 | Initial | $185,000 | No comparison | 4 | SEC filing |
| Jan 20, 2016 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Sep 11, 2015 | Initial | $721,180 | No comparison | 8 | SEC filing |
| Nov 17, 2014 | Initial | $238,500 | No comparison | 7 | SEC filing |
| Apr 2, 2014 | Initial | $753,220 | No comparison | 18 | SEC filing |
| Aug 22, 2012 | Initial | $3,832,214 | No comparison | 13 | SEC filing |
| Oct 27, 2011 | Initial | $675,057 | No comparison | 1 | SEC filing |
| Jan 22, 2010 | Initial | $1,500,000 | No comparison | 1 | SEC filing |
| Aug 13, 2009 | Initial | $5,886,291 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-373058
Source: Form D, filed Aug 12, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert F. Allnutt | Director |
| John F Benedick | Director |
| John F. Benedik | Director |
| David W. Carley | Director |
| Charles J. Casamento | Director |
| James H. Coleman | Executive |
| Carl W. Cotman | Director |
| Peter F. Drake | Director |
| Moogak Hwang | Director |
| Kathryn Hyer | Director |
| M Ross Johnson | Director |
| M. Ross Johnson | Director |
| Steven A. Johnson | Executive |
| Timothy Jones | Director, Executive |
| Peter W. Letendre | Director |
| Arnold S. Lippa | Director, Executive |
| Kathryn Mac Farlane | Director |
| James S. Manuso | Director, Executive |
| Jeff E. Margolis | Director, Executive |
| Maria Messinger | Executive |
| Richard Purcell | Executive |
| James E. Sapirstein | Director |
| Roger G. Stoll | Director, Executive |
| Pierre V Tran | Executive |
| Mark A. Varney | Director, Executive |
| Robert N. Weingarten | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
126 Valley Road Suite C
Glen Rock, NJ, 07452
Glen Rock, NJ, 07452